Vaneck Pharmaceutical ETF PPH

$90.00 +0.60 (0.67%)

Valuation

Market cap
—
Revenue TTM
—
Net income TTM
—
PE ratio
—
Forward PE
—
Profit margin
—
Debt to equity
—

Trading

Volume
106,427
Avg volume
—
Day's range
$89.58 – $90.26
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Phone
888-658-8287

Latest news

No headlines yet.